About Us

Our Company

Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have three approved ADHD products, two of which use our ODT technology and one of which is an ER oral suspension. Our growing ADHD product portfolio puts Neos in a unique position to help meet the different needs of patients who struggle with ADHD.